Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Brexit
June Raine has agreed to lead the Medicines and Healthcare products Regulatory Agency temporarily after the agency’s incumbent chief executive steps down in September.
As preparations for a no-deal Brexit intensify, the UK government has published a tender asking for freight operators to transport medical devices, medicine and other essential products to the UK, whether by air, land or sea, to “preserve human welfare.”
Recruitment Focus Part 2: How Brexit Is Threatening UK Companies’ Ability To Attract Sufficient Regulatory Talent
Medtech stakeholders are frantically stepping up recruitment efforts in order to have the human resources to implement the new EU Medical Device and IVD Regulations on time. But the UK has serious obstacles in its way of its own making. This is Part 2 of a three-part focus on the impact of the new regulations on recruitment in the EU.
News on EU standards was not what it first seemed this month, and the sector is becoming increasingly worried about delays. Medtech Insight explains the messy situation around standards and provides an overview of recent EU regulatory developments, including touching on fresh items of news.
Industry and the European Commission have been at loggerheads over whether the new EU Medical Device Regulation will be ready on time and whether a further extension is needed. Could recent notified body developments fuel the case for an extension?
In terms of a no-deal Brexit, the UK MHRA had drawn up its plans for medtech several months ago and is sticking by them. But even though manufacturers seemingly have more time to prepare for the delayed Brexit deadline, they should not underestimate the volume of work ahead.
A recent document from the European Commission concerning Brexit contingency measures is a new source of concern for medtech industry players. Is it a serious matter or a storm in a teacup?
It may often seem like Brexit is the only story in town in the UK, but within health care and medtech a lot of system transformation and future planning for access to medtech innovation is underway, as this installment of Medtech Insight's Device Week podcast with Ashley Yeo and Amanda Maxwell underlines.
Two UK notified bodies have made it clear that they want to remain active in the medtech space post-Brexit and issue UK certificates for the UK market. Medtech Insight asked them both about their plans.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.